Class 3 Medicines Recall: Bimatoprost Aspire 0.3mg/ml eye drops, solution in single-dose container, Aspire Pharma Limited, EL (21)A/26
Aspire Pharma Limited is recalling the below batches of Bimatoprost Aspire 0.3mg/ml eye drops, solution in single dose container 0.4ml x 30 as a precautionary measure.
MDR Number MDR 052-08/21
Company name Aspire Pharma Limited
Product description Bimatoprost Aspire 0.3mg/ml eye drops, solution in single dose container 0.4ml x 30 PL 35533/0128
Details of the affected batches:
|
Batch Number |
Expiry Date |
Pack Size |
First Distributed |
|
1590121 |
31/01/2023 |
30 |
04/03/21 |
|
1590221 |
31/01/2023 |
30 |
07/05/21 |
|
1590321 |
31/01/2023 |
30 |
28/06/21 |
|
1593920 |
31/01/2023 |
30 |
05/08/21 |
|
1594020 |
31/01/2023 |
30 |
21/09/21 |
Brief description of problem
Aspire Pharma Limited is recalling the above batches of Bimatoprost Aspire 0.3mg/ml eye drops, solution in single dose container 0.4ml x 30 as a precautionary measure due to the identification of some variability in the thickness of plastic of the single dose containers resulting in some patients finding the containers difficult to squeeze due to increased hardness of individual containers.
Advice to Healthcare Professionals
Stop supplying the above batches immediately. Quarantine all remaining stock and return it to your supplier using your supplier’s approved process.
Company contacts for further information
Customer Services for stock control enquiries:
Email: customerservices@aspirepharma.co.uk Tel. 01730 231148
Medical Information enquiries:
Email: medinfo@aspirepharma.co.uk Tel. 01730 231148
To access the full recall: Class 3 Medicines Recall: Bimatoprost Aspire 0.3mg/ml eye drops, solution in single-dose container, Aspire Pharma Limited, EL (21)A/26